Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Allergy | 1 |
| Clinics | 1 |
| Diseases | 1 |
| Dormitories | 1 |
| Health Services | 1 |
| Hospitals | 1 |
| Immunization Programs | 1 |
| Incidence | 1 |
| Injuries | 1 |
| Observation | 1 |
| Pain | 1 |
| More ▼ | |
Source
| Journal of American College… | 1 |
Author
| Bhavsar, Tina | 1 |
| Breakwell, Lucy | 1 |
| Briere, Elizabeth | 1 |
| Duffy, Jonathan | 1 |
| Ferris, Mary | 1 |
| Johnsen, Peter | 1 |
| Leighton, Kevin | 1 |
| McGilvray, Mark | 1 |
| McNamara, Lucy | 1 |
| Miller, Mary | 1 |
| Patel, Manisha | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
| Higher Education | 1 |
Audience
Location
| California | 1 |
| New Jersey | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkDuffy, Jonathan; Johnsen, Peter; Ferris, Mary; Miller, Mary; Leighton, Kevin; McGilvray, Mark; McNamara, Lucy; Breakwell, Lucy; Yu, Yon; Bhavsar, Tina; Briere, Elizabeth; Patel, Manisha – Journal of American College Health, 2017
Objective: To assess the safety of meningococcal group B (MenB)-4C vaccine. Participants: Undergraduates, dormitory residents, and persons with high-risk medical conditions received the MenB-4C vaccine two-dose series during mass vaccination clinics from 12/2013 through 11/2014. Methods: Adverse events (AEs) were identified by 15 minutes of…
Descriptors: Diseases, Immunization Programs, Hospitals, Safety
